Uesugi Miwa

Affiliation and department：
Papers (6)：

Mio Kikuchi, Yuki Okuda, Yoshihide Ueda, Yuki Nishioka, Miwa Uesugi, Emina Hashimoto, Tamotsu Takahashi, Tomoki Kawai, Sachiyo Hashi, Haruka Shinke, et al. Successful Telaprevir Treatment in Combination of Cyclosporine against Recurrence of Hepatitis C in the Japanese Liver Transplant Patients. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2014. 37. 3. 417-423
Miwa Uesugi, Mio Hosokawa, Haruka Shinke, Emina Hashimoto, Tamotsu Takahashi, Tomoki Kawai, Kazuo Matsubara, Kohei Ogawa, Yasuhiro Fujimoto, Shinya Okamoto, et al. Influence of Cytochrome P450 (CYP) 3A4*1G Polymorphism on the Pharmacokinetics of Tacrolimus, Probability of Acute Cellular Rejection, and mRNA Expression Level of CYP3A5 Rather than CYP3A4 in Living-Donor Liver Transplant Patients. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2013. 36. 11. 1814-1821
Masahide Fukudo, Ikuko Yano, Atsushi Yoshimura, Satohiro Masuda, Miwa Uesugi, Keiko Hosohata, Toshiya Katsura, Yasuhiro Ogura, Fumitaka Oike, Yasutsugu Takada, et al. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. PHARMACOGENETICS AND GENOMICS. 2008. 18. 5. 413-423
Masahide Fukudo, Ikuko Yano, Satohiro Masuda, Maki Goto, Miwa Uesugi, Toshiya Katsura, Yasuhiro Ogura, Fumitaka Oike, Yasutsugu Takada, Hiroto Egawa, et al. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. CLINICAL PHARMACOLOGY & THERAPEUTICS. 2006. 80. 4. 331-345
Miwa Uesugi, Satohiro Masuda, Toshiya Katsura, Fumitaka Oike, Yasutsugu Takada, Ken-ichi Inui. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients. PHARMACOGENETICS AND GENOMICS. 2006. 16. 2. 119-127

ｍore...

MISC (3)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page